Lexicon Pharmaceuticals (LXRX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $1.92 +1.59%
Revenue Growth %: -86.1%
Financial Fact:
Total revenues: 27.72M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -86.1%
Financial Fact:
Total revenues: 27.72M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $355 thousand versus the consensus estimate of $320 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
- MIND Technology (MIND) Misses Q1 EPS by 5c
- Driven Brands (DRVN) Tops Q4 EPS by 2c, Misses on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
